grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

November 30, 2017

Omnicell Showcases Comprehensive Solutions Portfolio at Annual ASHP Midyear Meeting

Download PDF

MOUNTAIN VIEW, Calif., Nov. 30, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, announced the Company will be showcasing the industry's most comprehensive and customizable platform of medication management automation solutions to optimize patient care from hospital to home at this year's American Society of Health-System Pharmacists 2017 Midyear Meeting, to be held in Orlando, FL from December 3-7.

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

Omnicell is revolutionizing the patient medication experience through an autonomous approach to medication management that leverages hardware and software to improve workflow, real-time predictive intelligence to enhance decision-making, and performance-driven partnerships that drive success and satisfaction.

According to a recent survey of health system C-suite leaders, 95 percent of respondents estimate drug expenses to increase by at least 10 percent over the next five years, with 16 percent of respondents estimating drug prices will climb by 30 percent or more.1 By leveraging technology to improve inventory control and effective medication management methods, hospitals can find ways to offset the effects of higher drug prices without sacrificing quality care.

"As healthcare providers struggle to meet the increasing challenges of medication management, ensuring availability, affordability, safety, and adherence across all settings is imperative to positive patient outcomes," said Joe Lynch, vice president, Marketing at Omnicell.  "Omnicell empowers our global healthcare partners to integrate and automate medication and supply management through hardware automation, workflow software and real-time predictive analytics that are transforming patient-centered care."

A broad range of Omnicell's portfolio of solutions will be displayed in booth #1101, including: 

Central Pharmacy
Omnicell offers a full suite of technologies that enable both hospital and retail pharmacies to automate manual processes to optimize inventory, floor space, and clinical staff time, and to monitor medication distribution anomalies and chain of custody in real time. These technologies help prevent medication errors, provide greater inventory control and visibility, and increase security for controlled substances.

At ASHP, Omnicell is introducing the XR2 Automated Central Pharmacy System, a revolutionary new technology that more fully automates medication inventory management, allowing pharmacies with both centralized and decentralized models to make a meaningful shift from operational demands to clinical contributions that impact patient outcomes.

IV Solutions
As a worldwide leader in IV compounding automation, Omnicell is the only company with a suite of solutions to fully automate IV preparation, including robotic hazardous and non-hazardous IV compounding, as well as semi-automated IV management systems. Omnicell's sterile compounding portfolio is augmented by unique data services, applications support, and expertise that enables hospitals and health systems to help enhance safety, improve therapy, reduce cost, and facilitate compliance related to sterile compounding processes.

IVX Workflow, a cloud based compact all-in-one package designed for safe, accurate, and streamlined IV sterile compounding, and a new addition to Omnicell's growing portfolio, will be featured at the exhibit.

Performance Center
Omnicell's Performance Center offering helps hospitals deal with the challenge of safely and effectively managing medications across a health system through a unique approach that combines expert services and real-time software. This unique approach helps optimize pharmacy supply chain and drives improved performance of enterprise pharmacy operations by monitoring data across the health system and recommending actions to help reduce inventory spend, manage medication shortages and expiration risk, and locate medications across a health system.

Medication Dispensing
Omnicell's XT series provides fast, secure, and versatile automated dispensing systems for the hospital floor, emergency department and operating room in a wide array of configurations along with software-only solutions to help institutions provide safe, high-quality care. Omnicell dispensing systems create safer, more efficient pharmacy and nursing workflow while providing better security for medications. This automation is ideal for acute care sites, including patient care floors and operating rooms, and for non-acute care sites such as skilled nursing facilities, rehabilitation centers, and clinics.

With the opioid epidemic reaching epic proportions and 1 in 10 healthcare providers abusing drugs at some point, Omnicell can help facilities reduce the risks associated with drug diversion.2Omnicell's portfolio includes easy-to-use, web-based diversion analytics software, which integrates with automated dispensing cabinets and other Omnicell automation, and enables a more effective and efficient way to monitor for potential drug diversion.

Medication Adherence
Omnicell has a complete set of solutions to support medication adherence. The unprecedented portfolio includes medication synchronization software, multimed adherence packaging, and related automation for use in hospital, retail, and community pharmacies.  These products help increase patient engagement and improve medication adherence, leading to better clinical and financial outcomes.

In addition to displaying a broad range of solutions in its booth, Omnicell will host several symposiums during the conference including: 

  • Panel discussion titled, "The Predictive Pharmacy: Leveraging Predictive Intelligence" on Sunday, December 3 at 4:30 p.m.
    Panelists include:
    Arpit Mehta, PharmD, MPH, System Pharmacy Manager, Inova Health System
    Jim Toohey, RPh, former Executive Director of Pharmacy, Aultman Hospital
    Ken Perez, Omnicell Vice President of Healthcare Policy, will be moderating
  • An Educational Symposium titled, "Extending Beyond-Use Dating and Batch Release Testing: Considerations for Your IV Room" on Tuesday, December 5 at 5:30 p.m.
    The speaker will be Thomas C. Kupiec, PhD, President and CEO of ARL Bio Pharma, with John Barickman, Senior Executive IV Pharmacist Consultant for Omnicell, moderating.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.

Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

1 "Premier Inc. C-Suite Survey: Healthcare Leaders Expanding Use of Generics, Educating Physicians on Therapeutic Alternatives to Control Drug Spending,"

2 Davenport, Courtney. Aug. 19, 2014, PNLRE-Newsletter. N.p., 2015.


View original content with multimedia:

SOURCE Omnicell, Inc.

News Provided by Acquire Media